Cytokines predict coronary aneurysm formation in Kawasaki disease patients

European Journal of Pediatrics

Volumn 152, Issue 4, 1993, Pages 309-312

  Lin, C Y ^a   Lin, C C ^a   Hwang, B ^a   Chiang, B N ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Interleukin 6; Interleukin 8; Kawasaki disease; Tumour necrosis factor

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; MARKER; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CORONARY ARTERY ANEURYSM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; ORAL DRUG ADMINISTRATION; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL;

CHILD, PRESCHOOL; CORONARY ANEURYSM; FEMALE; HUMAN; INFANT; INTERLEUKIN-6; INTERLEUKIN-8; INTERLEUKINS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RECEPTORS, INTERLEUKIN-2; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TUMOR NECROSIS FACTOR;

EID: 0027400619     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/BF01956740     Document Type: Article

References (19)

1. Neutrophil activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils
2. Cachectin and tumor necrosis factor as two sides of the same biological coin
3. Interferon beta 2/B cell stimulatory factor type 2 shars identify with monocyte-derived hepatocytestimulatory factor and regulates the major acute phase protein response in liver cells
4. Mucocutaneous lymph node syndrome-clinical observation of 50 cases
5. Kawasaki disease
6. The neutrophil-activating protein (NAP-1) in also chemotactic for T lymphcoytes
7. Immunologic aspects of Kawasaki disease: Implications for pathogenesis and therapy
8. Two monokines, interleukin-1 and tumor neucrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during kawasaki syndrome
9. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute kawasaki disease
10. Serial immunologic studies in patients with mucocutaneous lymph node syndrome (Kawasaki disease)
11. High risk factors in the development of coronary aneurysms in patients with mucocutaneous lymph node syndrome (Kawasaki disease)
12. The changes of interleukin-2, tumor necrotic factor and gamma-interferon production among patients with kawasaki disease
13. Cytokines as communication signals between leukocytes and endothelial cells
14. Elevated circulating tumor necrosis factor α in patients with kawasaki disease
15. Kawasaki syndrome: Clinical features, pathophysiology, etiology and therapy
16. The released interleukin-2 receptor binds interleukin-2 efficiently
17. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines
18. The acute phase nature of interleukin 6: studies in kawasaki disease and other febrile illness